AAAAAA
Results:
1-7
|
Results: 7
Authors:
WAGENKNECHT B
SCHULZ JB
GULBINS E
WELLER M
Citation: B. Wagenknecht et al., CRM-A, BCL-2 AND NDGA INHIBIT CD95L-INDUCED APOPTOSIS OF MALIGNANT GLIOMA-CELLS AT THE LEVEL OF CASPASE-8 PROCESSING, Cell death and differentiation, 5(10), 1998, pp. 894-900
Authors:
ROTH W
WAGENKNECHT B
DICHGANS J
WELLER M
Citation: W. Roth et al., INTERFERON-ALPHA ENHANCES CD95L-INDUCED APOPTOSIS OF HUMAN-MALIGNANT GLIOMA-CELLS, Journal of neuroimmunology, 87(1-2), 1998, pp. 121-129
Authors:
ROTH W
WAGENKNECHT B
GRIMMEL C
DICHGANS J
WELLER M
Citation: W. Roth et al., TAXOL MEDIATED AUGMENTATION OF CD95 LIGAND-INDUCED APOPTOSIS OF HUMAN-MALIGNANT GLIOMA-CELLS - ASSOCIATION WITH BCL-2 PHOSPHORYLATION BUT NEITHER ACTIVATION OF P53 NOR G(2) M CELL-CYCLE ARREST/, British Journal of Cancer, 77(3), 1998, pp. 404-411
Authors:
WAGENKNECHT B
TREPEL M
VONDEIMLING A
GRIMMEL C
ROLLBROCKER B
HAYASHI Y
LANG F
DICHGANS J
GULBINS E
WELLER M
Citation: B. Wagenknecht et al., P53 ACCUMULATION PROMOTES DEPHOSPHORYLATION AND PROTEOLYTIC CLEAVAGE OF RETINOBLASTOMA PROTEIN IN HUMAN-MALIGNANT GLIOMA-CELLS, Cellular physiology and biochemistry, 7(6), 1997, pp. 304-311
Authors:
WELLER M
WEINSTOCK C
WILL C
WAGENKNECHT B
DICHGANS J
LANG F
GULBINS E
Citation: M. Weller et al., CD95-DEPENDENT T-CELL KILLING BY GLIOMA-CELLS EXPRESSING CD95 LIGAND - MORE ON TUMOR IMMUNE ESCAPE, THE CD95 COUNTERATTACK, AND THE IMMUNE PRIVILEGE OF THE BRAIN, Cellular physiology and biochemistry, 7(5), 1997, pp. 282-288
Authors:
WAGENKNECHT B
GULBINS E
LANG F
DICHGANS J
WELLER M
Citation: B. Wagenknecht et al., LIPOXYGENASE INHIBITORS BLOCK CD95 LIGAND-MEDIATED APOPTOSIS OF HUMAN-MALIGNANT GLIOMA-CELLS, FEBS letters, 409(1), 1997, pp. 17-23
Authors:
WAGENKNECHT B
FREUDENRICH CC
LEFURGEY A
LIEBERMAN M
Citation: B. Wagenknecht et al., CALCIUM DEPLETION AND REPLETION IN CULTURED CHICK HEART-MUSCLE CELLS, Journal of Molecular and Cellular Cardiology, 26(7), 1994, pp. 797-808
Risultati:
1-7
|